Recent insider trading activity from Bairu Menghisteab, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Bairu Menghisteab | Director | A | Stock Option (Right to Buy) | 150000 | $0.70 | 150,000.0000 | 9,268,976 | 9999.99% | 1.62% |
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Bairu Menghisteab | Director | A | Common Stock | 24000 | $0.00 | 24,000.0000 | 5,021,798 | 9999.99% | 0.48% |